Company / Interest Expense
ENDONOVO THERAPEUTICS, INC. Interest Expense History
FY2019-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$941.6K
FY2021
5-year range
$17.0K / $2.1M
FY2019-FY2021
Trend
-54.8%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $17,000 to $941,566 over the past 2 years.
Based on SEC 10-K filings.
$941,566 in FY2021.
Increased from $17,000 to $941,566 over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, interest expense decreased 54.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -76.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | - | - |
| FY2021 | $941.6K | -54.8% |
| FY2020 | $2.1M | +12153.4% |
| FY2019 | $17.0K | - |
| FY2018 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
| FY2014 | - | - |
| FY2011 | - | - |
As of FY2021 · SEC 10-K · Updated Jun 29, 2026